0001140361-15-045632.txt : 20151228
0001140361-15-045632.hdr.sgml : 20151225
20151228111659
ACCESSION NUMBER: 0001140361-15-045632
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151222
FILED AS OF DATE: 20151228
DATE AS OF CHANGE: 20151228
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BioRestorative Therapies, Inc.
CENTRAL INDEX KEY: 0001505497
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
IRS NUMBER: 911835664
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 40 MARCUS DRIVE
CITY: MELVILLE
STATE: NY
ZIP: 11747
BUSINESS PHONE: (631) 760-8100
MAIL ADDRESS:
STREET 1: 40 MARCUS DRIVE
CITY: MELVILLE
STATE: NY
ZIP: 11747
FORMER COMPANY:
FORMER CONFORMED NAME: Stem Cell Assurance, Inc.
DATE OF NAME CHANGE: 20101110
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Weinreb Mark
CENTRAL INDEX KEY: 0001527212
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37603
FILM NUMBER: 151308293
MAIL ADDRESS:
STREET 1: STEM CELL ASSURANCE, INC.
STREET 2: 555 HERITAGE DRIVE
CITY: JUPITER
STATE: FL
ZIP: 33458
4
1
doc1.xml
FORM 4
X0306
4
2015-12-22
0
0001505497
BioRestorative Therapies, Inc.
BRTX
0001527212
Weinreb Mark
40 MARCUS DRIVE
MELVILLE
NY
11747
1
1
1
0
CEO and Chairman of the Board
Common Stock
85000
D
Stock Option
10
2010-12-15
2020-12-14
Common Stock
4000
4000
D
Stock Option
21
2022-02-09
Common Stock
50000
50000
D
Stock Option
30
2022-12-07
Common Stock
20000
20000
D
Stock Option
12
2023-10-04
Common Stock
12500
12500
D
Stock Option
13
2024-02-18
Common Stock
50000
50000
D
Stock Option
6.6
2024-10-23
Common Stock
150000
150000
D
Option
7
2015-12-22
4
A
0
208000
0
A
2025-09-04
Common Stock
208000
208000
D
The option is exercisable to the extent of 16,667 shares on each of February 10, 2012 and February 10, 2013 and 16,666 shares on February 10, 2014.
The option is exercisable to the extent of 10,000 shares on each of December 7, 2012 and December 7, 2013.
The option is exercisable to the extent of 6,250 shares on each of October 4, 2013 and October 4, 2014.
The option is exercisable to the extent of 16,667 shares on each of February 18, 2014 and February 18, 2015 and 16,666 shares on February 18, 2016.
The option is exercisable to the extent of 50,000 shares on each of October 23, 2015, October 23, 2016 and October 23, 2017.
On December 22, 2015, the stockholders of the Issuer approved amendments to the Issuer's 2010 Equity Participation Plan (the "Plan") to increase the number of shares authorized to be issued pursuant to the Plan to 2,250,000. The Reporting Person had been granted the option on September 4, 2015, subject to stockholder approval of such amendments.
The option is exercisable to the extent of 104,000 shares on December 22, 2015, 34,667 shares on each of September 4, 2016 and September 4, 2017, and 34,666 shares on September 4, 2018.
/s/ Mark Weinreb
2015-12-22